← Leaderboards
Alexander Monto
Veterans Affairs Med Ctr San Francisco
$0
Attributed
$0
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $0 · FY2011–19$1$1$1$0$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
VA$0 · 1
By mechanism
I01$0 · 1
Top collaborators
No co-investigators on record.
Most similar at Veterans Affairs Med Ctr San Francisco
Same institution · by research overlap
Others in their field
Top investigators on “San Francisco”
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Zvavahera Mike Chirenje · University Of California, San Francisco$118,149,266
- Barbara Driver · Westat, Inc.$95,724,261
- S. Claiborne Johnston · University Of California San Francisco$85,519,762
- Jennifer R Grandis · University Of Pittsburgh At Pittsburgh$80,769,502
- Mark S Anderson · University Of California, San Francisco$69,956,886
Research focus
San FranciscoPharmaceutical PreparationsPrimary Carcinoma Of The Liver CellsRaceLiver DiseasesMedical CenterDisease OutcomeFibrosisGeneticHepatorenal SyndromeInterferonsLiver BiopsyAlcohol ConsumptionMedicalAscitesChronic Hepatitis CCirrhosisEnrollmentAnti-Hepatitis CCohortHepatitis C TherapyHepatitis CAntiviral AgentsVeterans
Grant awards (8)
Optimizing Hepatitis C Therapies and Predicting Liver Disease Outcomes$0
I01 · FY2019 · VA · contact PI
Optimizing Hepatitis C Therapies and Predicting Liver Disease Outcomes$0
I01 · FY2018 · VA · contact PI
Optimizing Hepatitis C Therapies and Predicting Liver Disease Outcomes$0
I01 · FY2017 · VA · contact PI
Optimizing Hepatitis C Therapies and Predicting Liver Disease Outcomes$0
I01 · FY2016 · VA · contact PI
Viral Associated Liver Disease Phase III$0
I01 · FY2014 · VA · contact PI
Viral Associated Liver Disease Phase III$0
I01 · FY2013 · VA · contact PI
Viral Associated Liver Disease Phase III$0
I01 · FY2012 · VA · contact PI
Viral Associated Liver Disease Phase III$0
I01 · FY2011 · VA · contact PI